As men grow older, problems with urination become much more common. Many men find themselves waking several times each night to use the bathroom.
Others struggle to start urinating, feel that their bladder does not empty completely, or notice a much weaker urine stream. These problems can slowly affect sleep, daily routines, travel, work, and emotional well-being. While many people think these changes are simply a normal part of aging, they are often caused by an enlarged prostate.
An enlarged prostate, known medically as benign prostatic hyperplasia or BPH, is not cancer. It develops naturally in many men as they age. Because the prostate surrounds the tube that carries urine from the bladder, a larger prostate can narrow this passage and make urination difficult.
One of the most commonly prescribed medicines for BPH is tamsulosin. The medicine relaxes muscles around the prostate and bladder, making it easier for urine to pass.
For many men it provides noticeable relief, which explains why it has become one of the most widely used treatments for urinary symptoms. However, doctors have long wondered whether patients still benefit after taking the medicine for many years.
Scientists from the University of California, San Francisco decided to answer this question. Their research, published in JAMA Network Open, focused on older men who had already been taking tamsulosin for a long time. Instead of assuming the medicine was still working, the researchers carefully measured whether it actually continued to improve symptoms.
Each participant alternated between taking tamsulosin and an identical-looking placebo during short treatment periods. Neither the patients nor the researchers knew which treatment was being used at the time. This approach allowed the team to compare each person’s symptoms under both conditions.
The results showed that the response to tamsulosin was very different from one man to another. Around one-third of participants gained almost no extra benefit compared with the placebo. Another third experienced only modest improvement.
A much smaller group clearly benefited from continuing the medicine, while a few participants experienced worsening symptoms after switching to placebo and preferred to restart treatment.
According to lead researcher Dr. Scott R. Bauer, these findings suggest that long-term prescriptions should not simply continue year after year without review.
As people age, their health changes, new medicines are added, and the risk of side effects increases. Tamsulosin can sometimes cause dizziness, low blood pressure, falls, fractures, and additional medication burden, particularly in older adults.
The researchers believe regular medication reviews could help doctors decide whether each patient still needs tamsulosin. This approach could reduce unnecessary medicines while ensuring that men who truly benefit continue treatment.
The team also emphasized that patients should never stop taking prescription medicines without medical advice. Any decision to reduce or stop tamsulosin should be made together with a healthcare professional who can monitor symptoms and restart treatment if necessary.
Because this was a proof-of-concept study involving only 31 participants, larger studies are needed before the findings can be widely applied. Future research may identify which patients are most likely to continue benefiting from the medicine and which patients may safely stop it.
If you care about prostate cancer, please read studies about a natural ally against prostate cancer, and supplements and keto diet can boost immunotherapy for prostate cancer.
For more health information, please see recent studies about how to harness the power of anti-cancer foods and supplements, and low-fat diet may help stop cancer growth.
The research was published in JAMA Network Open.
Source: University of California, San Francisco.
